Next-Gen COVID Vaccines Could Be Awesome – If They Ever Get Made

Mucosal and other new vaccines in development should target infection and transmission prevention, as White House’s Ashish Jha calls for them to be ‘better than terrific.’ But with the market transitioning to a flu-like status, incentives for big investments seem limited.

Nasal COVID-19 vaccine
Nasal formulations are among the next generation COVID-19 vaccines in development. • Source: Shutterstock

White House officials have high expectations for the next generation of COVID-19 vaccines, a bar that may prove difficult to meet. Shifting market dynamics and a less hospitable research environment are now added to the scientific challenges that sponsors face. 

Increasing efficacy likely will not be enough to replace the roster of available shots. Ashish Jha, White House COVID-19 response...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet